Santhera Pharmaceuticals Holding AG (SANN.SW) Stock Overview
Explore Santhera Pharmaceuticals Holding AG’s financial performance, market position, analyst ratings, and future outlook.
Santhera Pharmaceuticals Holding AG (SANN.SW)
Key Financials
Key Financials
Market Cap
235.2M
P/E Ratio
-4.15
EPS (TTM)
$-3.83
ROE
6.85%
SANN.SW Stock Analysis & Investment Overview (SIX)
Our AI-powered analysis of Santhera Pharmaceuticals Holding AG (SIX: SANN.SW) gives investors deep insight into how the stock performs on the SIX exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Santhera Pharmaceuticals Holding AG's SIX-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of SANN.SW on the SIX shows an RSI of 56.36, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $17.45 for the SIX listing.
Key metrics behind Santhera Pharmaceuticals Holding AG's SIX-traded stock include a P/E ratio of -4.15 and a market capitalization of 235.2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of SANN.SW on the SIX.